SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-22-000140
Filing Date
2022-11-04
Accepted
2022-11-04 07:21:48
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20220930.htm   iXBRL 10-Q 1436210
2 EX-31.1 exhibit311-20220930q2.htm EX-31.1 9616
3 EX-31.2 exhibit312-20220930q2.htm EX-31.2 9517
4 EX-32.1 exhibit321-20220930q2.htm EX-32.1 4568
5 EX-32.2 exhibit322-20220930q2.htm EX-32.2 4589
  Complete submission text file 0001764013-22-000140.txt   4862565

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20220930.xsd EX-101.SCH 27475
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20220930_cal.xml EX-101.CAL 38833
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20220930_def.xml EX-101.DEF 168064
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20220930_lab.xml EX-101.LAB 406640
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20220930_pre.xml EX-101.PRE 271895
49 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20220930_htm.xml XML 558895
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 221360179
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences